JPWO2023150689A5 - - Google Patents
Info
- Publication number
- JPWO2023150689A5 JPWO2023150689A5 JP2024546193A JP2024546193A JPWO2023150689A5 JP WO2023150689 A5 JPWO2023150689 A5 JP WO2023150689A5 JP 2024546193 A JP2024546193 A JP 2024546193A JP 2024546193 A JP2024546193 A JP 2024546193A JP WO2023150689 A5 JPWO2023150689 A5 JP WO2023150689A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polynucleotide
- gjb2
- nucleic acid
- acid vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263306928P | 2022-02-04 | 2022-02-04 | |
| US202263306941P | 2022-02-04 | 2022-02-04 | |
| US63/306,928 | 2022-02-04 | ||
| US63/306,941 | 2022-02-04 | ||
| PCT/US2023/061953 WO2023150689A2 (en) | 2022-02-04 | 2023-02-03 | Gjb2 regulatory elements and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025506419A JP2025506419A (ja) | 2025-03-11 |
| JPWO2023150689A5 true JPWO2023150689A5 (https=) | 2026-02-04 |
| JP2025506419A5 JP2025506419A5 (https=) | 2026-02-04 |
Family
ID=87552983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546193A Pending JP2025506419A (ja) | 2022-02-04 | 2023-02-03 | Ｇｊｂ２調節エレメント及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250127928A1 (https=) |
| EP (1) | EP4473005A4 (https=) |
| JP (1) | JP2025506419A (https=) |
| KR (1) | KR20240156606A (https=) |
| AU (1) | AU2023214481A1 (https=) |
| CA (1) | CA3250345A1 (https=) |
| CL (1) | CL2024002306A1 (https=) |
| CO (1) | CO2024012057A2 (https=) |
| IL (1) | IL314705A (https=) |
| MX (1) | MX2024009520A (https=) |
| WO (1) | WO2023150689A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026025095A2 (en) | 2024-07-26 | 2026-01-29 | Regeneron Pharmaceuticals, Inc. | Otic drug delivery system and methods |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3159549A1 (en) * | 2019-10-30 | 2021-05-06 | Decibel Therapeutics, Inc. | Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems |
| EP4164695A4 (en) * | 2020-05-13 | 2024-06-05 | Akouos, Inc. | COMPOSITIONS AND METHODS FOR TREATING GJB2-ASSOCIATED HEARING LOSS |
-
2023
- 2023-02-03 CA CA3250345A patent/CA3250345A1/en active Pending
- 2023-02-03 AU AU2023214481A patent/AU2023214481A1/en active Pending
- 2023-02-03 IL IL314705A patent/IL314705A/en unknown
- 2023-02-03 MX MX2024009520A patent/MX2024009520A/es unknown
- 2023-02-03 EP EP23750443.6A patent/EP4473005A4/en active Pending
- 2023-02-03 US US18/835,452 patent/US20250127928A1/en active Pending
- 2023-02-03 WO PCT/US2023/061953 patent/WO2023150689A2/en not_active Ceased
- 2023-02-03 KR KR1020247029441A patent/KR20240156606A/ko active Pending
- 2023-02-03 JP JP2024546193A patent/JP2025506419A/ja active Pending
-
2024
- 2024-07-31 CL CL2024002306A patent/CL2024002306A1/es unknown
- 2024-09-04 CO CONC2024/0012057A patent/CO2024012057A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11834649B2 (en) | CRISPR/CAS-related methods and compositions for treating herpes simplex virus | |
| EP3353298B1 (en) | Allele selective gene editing and uses thereof | |
| EP3114227B1 (en) | Crispr/cas-related methods and compositions for treating usher syndrome and retinitis pigmentosa | |
| EP3498845B1 (en) | Crispr/cas-related methods and compositions for treating herpes simplex virus type 1 (hsv-1) | |
| US12460231B2 (en) | Crispr/CAS-related methods and compositions for treating primary open angle glaucoma | |
| JP2023075164A (ja) | アルファ１アンチトリプシン欠乏症を治療するための組成物および方法 | |
| CN118416088A (zh) | 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向 | |
| EP3129485A2 (en) | Crispr/cas-related methods and compositions for treating cystic fibrosis | |
| JP2023504190A (ja) | 遺伝子編集機構の脂質ナノ粒子送達のためのシステムおよび方法 | |
| WO2019224864A1 (ja) | Ｓｃｎ１ａ遺伝子の発現増強法とそれによるドラベ症候群の治療法 | |
| JP2022548399A (ja) | 肝細胞核因子４－アルファ（ＨＮＦ４α）遺伝子発現をモジュレートするための組成物および方法 | |
| JP2021530227A5 (https=) | ||
| CA3173528A1 (en) | Compositions and methods for modulating forkhead box p3 (foxp3) gene expression | |
| WO2023283359A2 (en) | Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression | |
| TW202444914A (zh) | 抑制子融合蛋白系統 | |
| CN117363594A (zh) | 一种可控制的RNA m6A去甲基化编辑系统及其应用 | |
| KR20240040112A (ko) | 방법 | |
| JPWO2023150689A5 (https=) | ||
| KR20260007637A (ko) | 원형 rna 및 이의 제조방법 | |
| JP2022548320A (ja) | アポリポタンパク質ｂ（ａｐｏｂ）遺伝子発現をモジュレートするための組成物および方法 | |
| RU2024123834A (ru) | Регуляторные элементы gjb2 и варианты их применения | |
| KR20230134097A (ko) | Nhej 복구 경로 조절을 통해 핵산 세그먼트의 결실 효율을 증가시키기 위한 조성물 및 방법 | |
| CN119487197A (zh) | 在工程化细菌中生产基因疗法载体 | |
| JPWO2023064388A5 (https=) | ||
| WO2026032020A1 (zh) | Aav介导的rpgr x连锁视网膜变性的基因编辑治疗方法 |